Biophytis Performance
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Biophytis are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Biophytis has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Biophytis is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors. ...more
Biophytis |
Biophytis Relative Risk vs. Return Landscape
If you would invest (100.00) in Biophytis on October 30, 2025 and sell it today you would earn a total of 100.00 from holding Biophytis or generate -100.0% return on investment over 90 days. Biophytis is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Biophytis, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Biophytis Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Biophytis for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Biophytis can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Biophytis is not yet fully synchronised with the market data | |
| Biophytis has some characteristics of a very speculative penny stock | |
| Biophytis has a very high chance of going through financial distress in the upcoming years | |
| Biophytishas 368,955 shares shorted by Biophytis investors is about 100% of outstending shares | |
| Net Loss for the year was (17.03 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Biophytis currently holds about 23.93 M in cash with (13.33 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.71. |
Biophytis Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Biophytis Stock often depends not only on the future outlook of the current and potential Biophytis' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Biophytis' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.4 M | |
| Cash And Short Term Investments | 5.6 M |
Biophytis Fundamentals Growth
Biophytis Stock prices reflect investors' perceptions of the future prospects and financial health of Biophytis, and Biophytis fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Biophytis Stock performance.
| Return On Equity | -12.44 | |||
| Return On Asset | -0.53 | |||
| Current Valuation | 9.73 B | |||
| Shares Outstanding | 286.5 K | |||
| Price To Book | 2.26 X | |||
| EBITDA | (15.09 M) | |||
| Cash And Equivalents | 23.93 M | |||
| Cash Per Share | 1.71 X | |||
| Total Debt | 8.27 M | |||
| Debt To Equity | 3.27 % | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (13.33 M) | |||
| Earnings Per Share | (128.39) X | |||
| Total Asset | 11.94 M | |||
| Retained Earnings | (19.38 M) | |||
Things to note about Biophytis performance evaluation
Checking the ongoing alerts about Biophytis for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Biophytis help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Biophytis is not yet fully synchronised with the market data | |
| Biophytis has some characteristics of a very speculative penny stock | |
| Biophytis has a very high chance of going through financial distress in the upcoming years | |
| Biophytishas 368,955 shares shorted by Biophytis investors is about 100% of outstending shares | |
| Net Loss for the year was (17.03 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Biophytis currently holds about 23.93 M in cash with (13.33 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.71. |
- Analyzing Biophytis' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Biophytis' stock is overvalued or undervalued compared to its peers.
- Examining Biophytis' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Biophytis' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Biophytis' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Biophytis' stock. These opinions can provide insight into Biophytis' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in Biophytis Stock
If you are still planning to invest in Biophytis check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biophytis' history and understand the potential risks before investing.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |